Profound Medical Corp.

NASDAQ: PROF
Share price (1/8/26): $8.48
Market cap (1/8/26): $255 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Supplemental info

Supplemental info

Registration of securities for employees

Ownership Filter

Menawat Arun Swarup

Gagnon Securities LLC

Gagnon Securities LLC

Letko, Brosseau & Associates Inc

News Filter

Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case Profound Medical Marks Major Milestone as the Hospital Launches Its State-Of-The-Art iMRI Suite to Expand Access to Advanced Prostate Care

Announces Closing of Private Placement

Announces Pricing of Up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

To Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings

Announces Strategic Distribution Agreement With Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Notice of effectiveness

Appointment of agent for service of process and undertaking

Notice of effectiveness

Appointment of agent for service of process and undertaking – amended